It depends on your health goals
But, the schedule might change based on how well the treatment works and the cause of the deficiency
The main concerns are local injection reactions, infection risk if sterility is breached, and misuse (e.g
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats
One fits repeated-entry handling
Pros: Extended half-life compared to unmodified MGF, in theory allowing fewer, more practical dosing intervals Mechanism aligns with well-studied endogenous muscle-repair biology (satellite cell activation, IGF-1 pathway) Widely available from research-chemical vendors for lab/research purposes Cons: No FDA approval, no completed human clinical trials, and no regulator-reviewed safety or efficacy data Prohibited in competitive sport under WADA growth-factor rules Product quality and purity vary significantly between unregulated research-chemical suppliers Side Effects: Not well characterized due to the absence of an approved label